tyrosine has been researched along with Adenocarcinoma Of Kidney in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 9 (39.13) | 2.80 |
| Authors | Studies |
|---|---|
| Aiglova, K; Melichar, B; Spisarova, M; Studentova, H; Szotkowski, T; Volakova, J; Zemankova, A | 1 |
| Çelik, S; Demir, MK; Kılıc, T; Moujawaz, R; Öven, BB; Somay, A | 1 |
| Chang, H; Qiao, Y; Shan, C; Su, M; Sun, H; Wang, J; Zhang, S; Zhao, Y | 1 |
| Bielska, AA; Harrigan, CF; Kyung, YJ; Morris, Q; Palm, W; Thompson, CB | 1 |
| Kanehira, M; Kato, R; Kato, Y; Maekawa, S; Matsuura, T; Obara, W; Takata, R | 1 |
| Arrowsmith, E; Bauer, TM; Choueiri, TK; D'Souza, A; Figlin, R; Heath, EI; McDermott, DF; Merchan, J; Michaelson, MD; Perini, R; Roy, A; Tykodi, SS; Vickery, D; Zhao, S | 1 |
| Arranz Arija, JÁ; Gallardo Díaz, E; González-Del-Alba, A; Lainez-Milagro, N; Lambea Sorrosal, J; Lázaro Quintela, M; Méndez-Vidal, MJ; Peláez Fernández, I; Perez-Valderrama, B; Suárez Rodriguez, C | 1 |
| Ando, K; Anzai, N; Furihata, T; Higuchi, K; Ichikawa, T; Ikehara, Y; Imamura, Y; Maimaiti, M; Matsushima, J; Nakamura, K; Okunushi, K; Reien, Y; Sakamoto, S; Sazuka, T; Takeshita, N | 1 |
| Bartenstein, P; Cyran, CC; Ilhan, H; Mittlmeier, LM; Rodler, S; Staehler, M; Stief, CG; Todica, A; Unterrainer, M | 1 |
| Armanini, F; Asnicar, F; Blanco-Miguez, A; Cammarota, G; Consolandi, C; Gasbarrini, A; Iacovelli, R; Ianiro, G; Lopetuso, LR; Masucci, L; Quaranta, G; Rossi, E; Sanguinetti, M; Schinzari, G; Segata, N; Settanni, CR; Thomas, AM; Tortora, G | 1 |
| Li, HZ; Liu, QM; Ma, X; Wang, PC; Zhang, X; Zhang, Y; Zhu, DQ; Zhu, J | 1 |
| Faridi, W; Gondal, FR; Husnain, M; Kohli, M; Malik, SU; Riaz, IB; Sipra, QUAR; Xie, H; Yadav, S | 1 |
| Abu Aboud, O; Weiss, RH; Wettersten, HI | 1 |
| Janovszky, A; Karg, E; László, A; Rózsa, M; Sallay, E; Tiszlavicz, L; Túri, S; Ugarte, M; Várkonyi, A; Wittmann, G | 1 |
| Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L | 1 |
| Abu Aboud, O; Bultman, S; Donohoe, D; Fitch, M; Hellerstein, M; Riiff, T; Weiss, RH | 1 |
| Anastasiadis, PZ; Copland, JA; Huveldt, D; Kourtidis, A; Yanagisawa, M | 1 |
| Bai, Y; Chen, YA; Dhillon, J; Fang, B; Fishman, M; Haake, SM; Haura, EB; Kinose, F; Koomen, JM; Li, J; Pow-Sang, JM; Rathmell, WK; Welsh, EA; Zent, R | 1 |
| Helin, H; Hirvikoski, P; Kallio, JP; Kellokumpu-Lehtinen, P; Kinnula, LV; Martikainen, PM; Peltoniemi, M; Soini, Y; Tammela, TL | 1 |
| Helin, H; Hirvikoski, P; Kallio, JP; Kang, SW; Kellokumpu-Lehtinen, P; Kinnula, VL; Martikainen, PM; Peltoniemi, M; Soini, Y; Tammela, TL | 1 |
| Kanda, S; Kanetake, H; Miyata, Y | 1 |
| Hamburger, AW; Mishra, S | 1 |
| Bander, NH; Feldman, M; Hicklin, DJ; Prewett, M; Rothman, M; Waksal, H | 1 |
3 review(s) available for tyrosine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
Topics: Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Kidney Neoplasms; Tyrosine | 2022 |
Isolated Pituitary Metastasis of Renal Cell Carcinoma: A Case Report and Systematic Review of the Literature.
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Middle Aged; Pituitary Neoplasms; Sunitinib; Tyrosine | 2022 |
Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nephrectomy; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Tyrosine; Vascular Endothelial Growth Factor A | 2019 |
2 trial(s) available for tyrosine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Immunotherapy; Male; Middle Aged; Protein Kinase Inhibitors; Tyrosine | 2023 |
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Diarrhea; Double-Blind Method; Drug Therapy; Dysbiosis; Enzyme Inhibitors; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Kidney Neoplasms; Male; Middle Aged; Tissue Donors; Tyrosine | 2020 |
18 other study(ies) available for tyrosine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Dioxygenases; Female; Glutathione Transferase; Homogentisate 1,2-Dioxygenase; Humans; Kidney; Kidney Neoplasms; Male; Tyrosine | 2022 |
Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions.
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Mutation; Nutrients; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Tyrosine | 2022 |
Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors.
Topics: Carcinoma, Renal Cell; Humans; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Nivolumab; Tyrosine | 2022 |
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Nivolumab; Quality of Life; Sunitinib; Tyrosine | 2023 |
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.
Topics: Benzoxazoles; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Kidney Neoplasms; Large Neutral Amino Acid-Transporter 1; Male; Middle Aged; Prognosis; Progression-Free Survival; Retrospective Studies; Tyrosine | 2019 |
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Edetic Acid; Glutamate Carboxypeptidase II; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tyrosine | 2020 |
MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
Topics: Adult; Angiogenesis Inducing Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Kidney Neoplasms; Male; MicroRNAs; Middle Aged; Receptors, Somatotropin; Signal Transduction; STAT3 Transcription Factor; Tyrosine | 2019 |
Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Deoxyglucose; G1 Phase; Glucose; Glycolysis; Humans; Immunoblotting; Immunohistochemistry; Kidney Neoplasms; Oxazoles; PPAR alpha; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; RNA Interference; Tyrosine | 2013 |
The fate of tyrosinaemic Hungarian patients before the NTBC aera.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child, Preschool; Cyclohexanones; Enzyme Inhibitors; Fatal Outcome; Homozygote; Humans; Hungary; Hydrolases; Kidney Neoplasms; Liver Neoplasms; Male; Nitrobenzoates; Treatment Outcome; Tyrosine; Tyrosinemias | 2013 |
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2014 |
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
Topics: Animals; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kidney Tubules; Metabolic Networks and Pathways; Mice; Mice, Nude; Organ Specificity; Oxazoles; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; Tyrosine; Xenograft Model Antitumor Assays | 2015 |
Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer.
Topics: Blotting, Western; Breast Neoplasms; Carcinoma, Renal Cell; Catenins; Cell Transformation, Neoplastic; Delta Catenin; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Kidney Neoplasms; Phosphoproteins; Phosphorylation; Protein Binding; Serine; Threonine; Tissue Array Analysis; Tumor Cells, Cultured; Tyrosine | 2015 |
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Topics: Carcinoma, Papillary; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; ErbB Receptors; Extracellular Matrix; Humans; Kidney Neoplasms; Mass Spectrometry; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteomics; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2016 |
Antioxidant enzymes in renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Catalase; Female; Glutamate-Cysteine Ligase; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Neoplasms; Male; Middle Aged; Superoxide Dismutase; Thioredoxin-Disulfide Reductase; Thioredoxins; Tyrosine | 2006 |
Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blotting, Western; Carcinoma, Renal Cell; Humans; Immunohistochemistry; Kidney Neoplasms; Middle Aged; Neoplasm Staging; Nephrectomy; Oxidative Stress; Peroxidases; Peroxiredoxins; Prognosis; Survival Analysis; Tyrosine | 2006 |
Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-met; Retrospective Studies; Tumor Cells, Cultured; Tyrosine | 2006 |
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Division; Cetuximab; Disease Models, Animal; ErbB Receptors; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Recombinant Fusion Proteins; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine | 1998 |